Skip navigation

New Models for Direct Contracting, Hospital Sales and Data Management to Drive Product Success in Evolving Health Systems

August 16-17, 2017
  • Philadelphia, PA

As health systems continue to grow and consolidate to form major Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with, and sell to, these evolving systems to ensure product success. With conflict of interest policies in place and restricted access to physicians, manufacturers are changing their sales approach to better reach and engage these new customers. CBI’s Partnering with IDNs Strategy Summit convenes manufacturers and IDNs to discuss how to create a mutually beneficial partnership that contributes to continual care coordination, strategic product management and enhanced access.

Key Explorations Include:

  • The IDN model of patient care coordination and what it can do to improve the patient experience on behalf of the provider, manufacturer, payer and other stakeholders
  • Changes in the hospital reimbursement model, focused on quality tied to outcomes measures
  • Effective ways manufacturers can partner with health systems
  • Understand the size and scope of the current US hospital marketplace and the GPO’s contracting relationships with those providers
  • Explore implications of value-based RWE on the healthcare manufacturing community in terms of contracting, distribution, and consumer engagement with payers and providers
  • Gain perspective on how IDN SPs are gaining manufacturer network access

Previous Attendee Acclaim:

A forward-thinking conference grounded in real reasons for
the change. This conference could easily expand to 10 times
its current size as these changes take hold.

Director, Team Leader, U.S. Payer & Channel Access, Pfizer Inc

Our company is new to exploring IDNs. This conference was an amazing way to learn more about the landscape and understand how others are attempting to engage this ‘new’ target.

Director, Managed Markets, Grifols

Great opportunity to hear peers from all aspects of the IDN
to see the holistic picture.

Senior Director, Acentrus

Well planned content from experts that will help me create
a strategy in this space.

Account Executive-Biopharm, Novo Nordisk

Great interaction between stakeholders.

Vice President, Acentrus

August 16-17, 2017 Wyndham Historic District Philadelphia, PA

Partnering with IDNs BioPharma Strategy Summit

New Models for Direct Contracting, Hospital Sales and Data Management to Drive Product Success in Evolving Health Systems

As health systems continue to grow and consolidate to form major Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with, and sell to, these evolving systems to ensure product success. With conflict of interest policies in place and restricted access to physicians, manufacturers are changing their sales approach to better reach and engage these new customers. CBI’s Partnering with IDNs Strategy Summit convenes manufacturers and IDNs to discuss how to create a mutually beneficial partnership that contributes to continual care coordination, strategic product management and enhanced access.

Key Explorations Include:

  • The IDN model of patient care coordination and what it can do to improve the patient experience on behalf of the provider, manufacturer, payer and other stakeholders
  • Changes in the hospital reimbursement model, focused on quality tied to outcomes measures
  • Effective ways manufacturers can partner with health systems
  • Understand the size and scope of the current US hospital marketplace and the GPO’s contracting relationships with those providers
  • Explore implications of value-based RWE on the healthcare manufacturing community in terms of contracting, distribution, and consumer engagement with payers and providers
  • Gain perspective on how IDN SPs are gaining manufacturer network access

Previous Attendee Acclaim:

A forward-thinking conference grounded in real reasons for
the change. This conference could easily expand to 10 times
its current size as these changes take hold.

Director, Team Leader, U.S. Payer & Channel Access, Pfizer Inc

Our company is new to exploring IDNs. This conference was an amazing way to learn more about the landscape and understand how others are attempting to engage this ‘new’ target.

Director, Managed Markets, Grifols

Great opportunity to hear peers from all aspects of the IDN
to see the holistic picture.

Senior Director, Acentrus

Well planned content from experts that will help me create
a strategy in this space.

Account Executive-Biopharm, Novo Nordisk

Great interaction between stakeholders.

Vice President, Acentrus

August 16-17, 2017 Wyndham Historic District Philadelphia, PA